YIPF5 and cervical carcinoma: From the findings obtained, we have proposed a model for how Yip1A functions as a prosurvival modulator that coordinately activates the IRE1 and PERK pathways of the UPR to support the survival of HeLa and CaSki cervical cancer cells (Figure 7).